EHI
DXCM icon

Eagle Health Investments’s DexCom DXCM Stock Holding History

Eagle Health Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-273,821
Closed -$23.9M – 24
2025
Q2 		$23.9M Sell
273,821
-83,100
-23% -$6.51M 5.9% 7
2025
Q1 		$24.4M Buy
356,921
+82,370
+30% +$6.72M 6.33% 8
2024
Q4 		$21.4M Sell
274,551
-176,941
-39% -$13.1M 5.23% 9
2024
Q3 		$30.3M Buy
451,492
+175,774
+64% +$14.4M 5.73% 8
2024
Q2 		$31.3M Sell
275,718
-9,200
-3% -$1.16M 5.48% 8
2024
Q1 		$39.5M Sell
284,918
-24,400
-8% -$3.07M 7.34% 5
2023
Q4 		$38.4M Buy
309,318
+33,213
+12% +$3.39M 7.8% 5
2023
Q3 		$25.8M Buy
276,105
+113,705
+70% +$12.8M 5.68% 8
2023
Q2 		$20.9M Sell
162,400
-69,200
-30% -$8.37M 3.9% 13
2023
Q1 		$26.9M Buy
231,600
+12,600
+6% +$1.41M 5.24% 9
2022
Q4 		$24.8M Sell
219,000
-46,800
-18% -$5.14M 5.72% 10
2022
Q3 		$21.4M Buy
265,800
+28,700
+12% +$2.43M 4.91% 10
2022
Q2 		$17.7M Buy
237,100
+81,500
+52% +$7.44M 4.12% 10
2022
Q1 		$19.9M Buy
155,600
+48,800
+46% +$5.34M 4.9% 9
2021
Q4 		$14.3M Sell
106,800
-11,200
-9% -$1.61M 3.49% 15
2021
Q3 		$16.1M Sell
118,000
-18,800
-14% -$2.37M 5.12% 10
2021
Q2 		$14.6M Buy
136,800
+81,600
+148% +$7.84M 5.01% 9
2021
Q1 		$4.96M Hold
55,200
– – 1.95% 19
2020
Q4 		$5.1M Buy
+55,200
New +$4.93M 3.26% 14

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Eagle Health Investments's DXCM Position: Q3 2025 in Review

Eagle Health Investments sold out of DexCom (DXCM) in Q3 2025, closing a stake of 273,821 shares — an estimated $23.9M sold.

Eagle Health Investments first reported a position in DXCM in Q4 2020 and held it in 19 quarters. The position peaked at $39.5M in Q1 2024. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Eagle Health Investments reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Eagle Health Investments sold 273,821 DexCom shares in Q3 2025, an estimated $23.9M.
  • Eagle Health Investments first reported a position in DexCom in Q4 2020 and held it in 19 quarters.
  • Eagle Health Investments's DexCom position peaked at $39.5M in Q1 2024.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Eagle Health Investments's 13F filing for Q3 2025, filed 7 Nov 2025.